a public good project by the
Synthesis
Company
of California

© 2026

Andrzej Horban | doi.page

0 works0 citations0 h-index

Andrzej Horban

Medical University of Warsaw(PL)

Publications by Year

Research Areas

Hepatitis C virus research, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies

Most-Cited Works

→ Telaprevir for Retreatment of HCV Infection(2011)1,534 cited
→ Maraviroc for Previously Treated Patients with R5 HIV-1 Infection(2008)737 cited
→ Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study(2004)683 cited
→ Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management(2005)420 cited
→ Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy(2005)384 cited
→ Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease(2010)320 cited

→ Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1(2004)

274 cited

→ Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection(2010)265 cited

→ Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial(2014)254 cited

→ The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus(2008)223 cited